Trial Profile
A Pharmacokinetic Study Assessing the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Emixustat in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2020
Price :
$35
*
At a glance
- Drugs Emixustat (Primary)
- Indications Diabetic retinopathy; Dry age-related macular degeneration; Stargardt disease
- Focus Pharmacokinetics
- 20 Feb 2020 According to an Acucela media release, the company has changed its name to Kubota Vision, effective from 1 Apr 2020.
- 20 Sep 2018 New trial record